红豆杉资源加工利用产业发展现状

红豆杉是广谱抗肿瘤药物——紫杉醇的天然来源，国际市场对紫杉醇的需求量逐年增长，我国虽然红豆杉储量已超过世界储量二分之一，出口量约占世界总产量四分之一，但出口产值仅占世界紫杉醇总产值十分之一，因此，如何在现有基础上快速提高红豆杉产品附加值并建立完整的高附加值产业链是我国红豆杉产业发展的关键。在此基础上，本研究对红豆杉资源储量、产品类型、产品质量控制及其分析检测方法、技术瓶颈及产业规模等进行了调研，对我国当前红豆杉产业存在的野生资源稀少、人工资源缺乏统一规划布局以及缺乏高附加值产品等问题的原因进行了分析，对红豆杉产业未来资源储量、技术创新方向及产业发展规划提出了建议，可为红豆杉资源绿色产业化发展提供理论基础和数据支持。

Industrialization Development Status of Taxus Resources

Taxus is the natural source of paclitaxel that is a broad-spectrum anti-tumor drug. Chinese Taxus resources account more than half of the global reserves and the exports account for a quarter of the world's total production, but the Taxus export value accounts only one tenth of the world's total output value. Therefore, how to quickly increase the added value of Taxus products and establish a complete high value-added industrial chain is the key to the development of Taxus industry. Consequently, the resource reserves, product types, product quality control and its analytical control methods, technical bottlenecks and industrial scale of Taxus were investigated in this study. The reasons for the lack of wild resources, unified planning and layout of artificial resources and high price products in current Chinese yew industry were analyzed. At last, the suggestion on the resource reserves, technological innovation directions and industrial development plans of Taxus were provided. This study may provide theoretical basis and data support for the green industrialization of Taxus.